Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Embolic Protection in Patients Undergoing High-Risk Valve Surgery

NCT06027788 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.

NCT NCT06027788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06027788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Embolic Protection in Patients Undergoing High-Risk Valve Surgery
Lead sponsor
Icahn School of Medicine at Mount Sinai
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 18, 2023
Completion date
April 1, 2027
Enrollment
842 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, coronary artery disease, delirium, heart valve disease, ischemic stroke